These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12175635)

  • 41. Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen.
    Kaech C; Pache I; Bürgisser P; Elzi L; Darling KE; Cavassini M
    J Infect; 2012 Aug; 65(2):157-64. PubMed ID: 22410383
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Vaccination against hepatitis B in patients with chronic renal failure--twenty years follow-up].
    Roznovský L; Tvrdík J; Kabieszová L; Petrousová L; Orságová I; Hozáková L; Lochman I; Kloudová A; Valkovský I; Letocha P; Schwarzová S; Hladík M; Zjevíková A
    Vnitr Lek; 2011 Oct; 57(10):808-14. PubMed ID: 22097688
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings.
    Craven DE; Awdeh ZL; Kunches LM; Yunis EJ; Dienstag JL; Werner BG; Polk BF; Syndman DR; Platt R; Crumpacker CS
    Ann Intern Med; 1986 Sep; 105(3):356-60. PubMed ID: 2943202
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HLA genetic heterogeneity of hepatitis B vaccine response in hemodialyzed patients.
    Caillat-Zucman S; Gimenez JJ; Albouze G; Lebkiri B; Naret C; Jungers P; Bach JF
    Kidney Int Suppl; 1993 Jun; 41():S157-60. PubMed ID: 8320910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis B immune status in adolescents vaccinated during infancy: A retrospective cohort study from a pediatric practice in Germany.
    Anderson CL; Remschmidt C; Drobnitzky FP; Falkenhorst G; Zimmermann R; Wichmann O; Harder T
    Hum Vaccin Immunother; 2016 Mar; 12(3):779-84. PubMed ID: 26633195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccine among low-responder infants following primary vaccination: 4-year of follow-up].
    Lyu JJ; Yan BY; Liu JY; Feng Y; Wu WL; Liang XF; Cui FQ; Wang FZ; Zhang GM; Xu AQ; Zhang L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):490-495. PubMed ID: 28592091
    [No Abstract]   [Full Text] [Related]  

  • 47. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
    Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
    Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intradermal hepatitis B vaccination in non-responders after topical application of imiquimod (Aldara).
    Roukens AH; Vossen AC; Boland GJ; Verduyn W; van Dissel JT; Visser LG
    Vaccine; 2010 Jun; 28(26):4288-93. PubMed ID: 20433806
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Higher numbers of memory B-cells and Th2-cytokine skewing in high responders to hepatitis B vaccination.
    Doedée AM; Kannegieter N; Öztürk K; van Loveren H; Janssen R; Buisman AM
    Vaccine; 2016 Apr; 34(19):2281-9. PubMed ID: 26721327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibody response to hepatitis B vaccine in end-stage renal disease patients.
    Chow KM; Law MC; Leung CB; Szeto CC; Li PK
    Nephron Clin Pract; 2006; 103(3):c89-93. PubMed ID: 16534237
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine.
    Krawczyk A; Ludwig C; Jochum C; Fiedler M; Heinemann FM; Shouval D; Roggendorf M; Roggendorf H; Lindemann M
    Vaccine; 2014 Sep; 32(39):5077-82. PubMed ID: 24975813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monitoring the efficacy of infant hepatitis B vaccination and revaccination in 0- to 8-year-old children: Protective anti-HBs levels and cellular immune responses.
    Li X; Xu Y; Dong Y; Yang X; Ye B; Wang Y; Chen Y
    Vaccine; 2018 Apr; 36(18):2442-2449. PubMed ID: 29588118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized, comparative trial of 20 micrograms vs 40 micrograms Engerix B vaccine in hepatitis B vaccine non-responders.
    Goldwater PN
    Vaccine; 1997 Mar; 15(4):353-6. PubMed ID: 9141204
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Non- and low-response after preventive hepatitis B vaccination].
    Hasselhorn HM; Kralj N; Hofmann F; Nübling M; Berthold H
    Gesundheitswesen; 1997 May; 59(5):321-8. PubMed ID: 9289224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond.
    Martinetti M; De Silvestri A; Belloni C; Pasi A; Tinelli C; Pistorio A; Salvaneschi L; Rondini G; Avanzini MA; Cuccia M
    Clin Immunol; 2000 Dec; 97(3):234-40. PubMed ID: 11112362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.
    Gara N; Abdalla A; Rivera E; Zhao X; Werner JM; Liang TJ; Hoofnagle JH; Rehermann B; Ghany MG
    Clin Infect Dis; 2015 Feb; 60(4):505-13. PubMed ID: 25389254
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigation of memory B cell responses to hepatitis B surface antigen in health care workers considered as non-responders to vaccination.
    Valats JC; Tuaillon E; Funakoshi N; Hoa D; Brabet MC; Bolloré K; Ducos J; Vendrell JP; Blanc P
    Vaccine; 2010 Sep; 28(39):6411-6. PubMed ID: 20682363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sci-B-VacTM Vs ENGERIX-B Vaccines for Hepatitis B Virus in Patients with Inflammatory Bowel Diseases: A Randomised Controlled Trial.
    Etzion O; Novack V; Perl Y; Abel O; Schwartz D; Munteanu D; Abufreha N; Ben-Yaakov G; Maoz ED; Moshaklo A; Dizingf V; Fich A
    J Crohns Colitis; 2016 Aug; 10(8):905-12. PubMed ID: 26928962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination.
    Tsouchnikas I; Dounousi E; Xanthopoulou K; Papakonstantinou S; Thomoglou V; Tsakiris D
    Clin Nephrol; 2007 Oct; 68(4):228-34. PubMed ID: 17969490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunogenicity of three recombinant hepatitis B vaccines administered to students in three doses containing half the antigen amount routinely used for adult vaccination.
    Baldy JL; de Lima GZ; Morimoto HK; Reiche EM; Matsuo T; de Mattos ED; Sudan LC
    Rev Inst Med Trop Sao Paulo; 2004; 46(2):103-7. PubMed ID: 15141282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.